0 results for 'Sanofi SA'
FTC Chair Intends to Keep Fighting Pharma Payments to Generic Competitors
The Federal Trade Commission so far has been unable to block drug companies from reaching settlements it fears are slowing the introduction of generic competitors, but the head of the agency said she won't stop fighting to end such deals. FTC Chairman Deborah Platt Majoras said she's concerned payments by brand name drug makers to their generic rivals may be nothing more than payoffs to keep cheap drugs off the market, depriving consumers of low-cost medicines.Icahn's Influence Could Dictate ImClone's Decision to Appeal Patent Ruling
Carl Icahn isn't getting his way, at least not yet. ImClone Systems responded to its most famous shareholder's latest attacks by giving him a board seat but keeping Chairman David Kies, despite Icahn's continued public thrashing of him. One indication of Icahn's influence could come in the legal battle over a key patent behind ImClone's sole marketed product, cancer fighter Erbitux. If ImClone reverses course and drops its appeal of the patent case, it would be a concession to one of Icahn's public demands.CVS $25 billion benefit looms with Caremark breakup: real M&A
CVS Caremark Corp., created in a takeover four years ago that has left investors with underperforming stock, could be worth $25 billion more if the company split itself up.Break into 'Meinhattan' market
By Brenda Sandburg, The American LawyerFrankfurt may be Germany's Manhattan, or "Meinhattan," as the locals call it, but this Monday morning in February it's fairly quiet, free of the constant crush of people that makes the Big Apple hum. From the thirty-fifth floor of the Main Tower, a 600-foot cylinder in the heart of the city, Christof von Dryander has a commanding view of the gently curving Mein River.CVS $25 billion benefit looms as SunAmerica agitates for breakup
CVS Caremark Corp. (CVS), created in a takeover four years ago that has left investors with underperforming stock, could be worth $25 billion more if the company split itself up.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now